Delivery Order SPE2DB20D3103-SPE2DB24FQ0T0
Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of 60-count bottles of Naltrexone 50 mg tablets. The contract has a ceiling value of $2,770.67 and a completion date of July 25, 2024. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor for this award, which is not designated as a set-aside. The contract is a firm-fixed-price delivery order, meaning AmerisourceBergen will provide the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 60-count Naltrexone 50 mg tablets. The contract has a ceiling value of $5,187.32 and an ultimate completion date of August 16, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,332.54, is for the delivery of 60-count packages of the pharmaceutical product Naltrexone 50 mg tablets. The contract has a completion date of November 18, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the delivery of Naltrexone 50 mg tablets in 90-count packages, with a ceiling value of $7,106.19 and a performance period through March 13, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
- This is a $31,904.62 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60-count packages of the drug Naltrexone 50 mg tablets. The contract has an ultimate completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of naltrexone 50 mg tablets. The contract has a firm fixed-price structure and a ceiling value of $3,631.94. It is not associated with any set-aside designation. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. Amerisourcebergen Drug Corp, through its Corporate Office Division, is a...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Naltrexone 50 mg tablets. The contract has a ceiling value of $6,028.72 and a completion date of May 21, 2025. It was awarded on May 20, 2025 by the Defense Logistics Agency (DLA), a defense agency, as a firm fixed-price delivery order contract. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Naltrexone 50 mg tablets, a medication used to treat opioid addiction. The contract is a firm-fixed price delivery order with a ceiling value of $7,192.66 and a period of performance ending on May 2, 2025. This order is not set aside for any particular business type. AmerisourceBergen Drug Corp holds a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The order is for the supply of Naltrexone 50 mg tablets, a pharmaceutical product, at a firm fixed price of $1,308.12. The contract has a completion date of December 20, 2023. Amerisourcebergen Drug Corp has received multiple federal contract awards from DLA to provide...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 60-count tablets of the drug Naltrexone 50 mg, a medication used to treat opioid and alcohol dependence. The contract has a ceiling value of $12,670.26 and an ultimate completion date of October 24, 2024. This delivery order is a part of a larger Indefinite Delivery...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FQ0T0Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Naltrexone 50 mg tablets. The contract has a firm fixed-price pricing structure and a ceiling value of $2,121.33. It does not have a set-aside designation. The contract supports the delivery of this essential pharmaceutical product to military treatment facilities and other federal healthcare providers. AmerisourceBergen, through its extensive supply chain network, is responsible for providing this critical medication to meet the needs of the U.S. government's defense and healthcare programs. The contract has an ultimate completion date of August 29, 2024.
Generated 11/27/24, 9:36 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 8/28/24 |